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PCardiac Imaging
Long-Term Prognosis Associated With Coronary Calcification
Observations From a Registry of 25,253 Patients
Matthew J. Budoff, MD,* Leslee J. Shaw, PHD,† Sandy T. Liu,* Steven R. Weinstein,*
Tristen P. Mosler, Philip H. Tseng,* Ferdinand R. Flores,* Tracy Q. Callister, MD,‡
Paolo Raggi, MD,§ Daniel S. Berman, MD†
Torrance and Los Angeles, California; Nashville, Tennessee; and Atlanta, Georgia
Objectives The purpose of this study was to develop risk-adjusted multivariable models that include risk factors and coro-
nary artery calcium (CAC) scores measured with electron-beam tomography in asymptomatic patients for the
prediction of all-cause mortality.
Background Several smaller studies have documented the efficacy of CAC testing for assessment of cardiovascular risk.
Larger studies with longer follow-up will lend strength to the hypothesis that CAC testing will improve outcomes,
cost-effectiveness, and safety of primary prevention efforts.
Methods We used an observational outcome study of a cohort of 25,253 consecutive, asymptomatic individuals referred
by their primary physician for CAC scanning to assess cardiovascular risk. Multivariable Cox proportional hazards
models were developed to predict all-cause mortality. Risk-adjusted models incorporated traditional risk factors
for coronary disease and CAC scores.
Results The frequency of CAC scores was 44%, 14%, 20%, 13%, 6%, and 4% for scores of 0, 1 to 10, 11 to 100,
101 to 400, 401 to 1,000, and 1,000, respectively. During a mean follow-up of 6.8  3 years, the death
rate was 2% (510 deaths). The CAC was an independent predictor of mortality in a multivariable model con-
trolling for age, gender, ethnicity, and cardiac risk factors (model chi-square  2,017, p  0.0001). The
addition of CAC to traditional risk factors increased the concordance index significantly (0.61 for risk fac-
tors vs. 0.81 for the CAC score, p  0.0001). Risk-adjusted relative risk ratios for CAC were 2.2-, 4.5-, 6.4-,
9.2-, 10.4-, and 12.5-fold for scores of 11 to 100, 101 to 299, 300 to 399, 400 to 699, 700 to 999, and
1,000, respectively (p  0.0001), when compared with a score of 0. Ten-year survival (after adjustment
for risk factors, including age) was 99.4% for a CAC score of 0 and worsened to 87.8% for a score of
1,000 (p  0.0001).
Conclusions This large observational data series shows that CAC provides independent incremental information in addition to
traditional risk factors in the prediction of all-cause mortality. (J Am Coll Cardiol 2007;49:1860–70) © 2007
by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.10.079p
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Evidence-based guidelines recommend that
primary care physicians make a careful assess-
ment of their patients’ baseline coronary
heart disease (CHD) risk and focus primary
prevention interventions (such as use of
cholesterol-lowering drugs [1] and aspirin
2]) on intermediate- and high-risk patients. Standard
isk factor analyses can help stratify patients into risk
roups but are somewhat imprecise and leave a large
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oundation, Nashville, Tennessee; and the §Division of Cardiology and Department
f Radiology, Emory University, Atlanta, Georgia. Dr. Budoff is on the speakers’
ureau for General Electric.E
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006, accepted October 16, 2006.roportion of patients classifiable as “intermediate” risk, a
ather undetermined state. Cholesterol therapy of pa-
ients in this category might range from no therapy to a
ow-density lipoprotein target 100 mg/dl. More effec-
ive assessment of CHD risk might improve the outcome,
See page 1871
ost-effectiveness, and safety of primary prevention ef-
orts. We attempted to assess the prognostic power of
oronary artery calcium (CAC) assessed with electron
eam tomography (EBT). The purpose of this study was
o develop long-term risk-adjusted multivariable predic-
ive models to estimate death from all-causes, using
ardiac risk factors and CAC scores determined with
BT.
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atient entry criteria. The study sample consisted of 25,253
onsecutive asymptomatic individuals referred by primary
hysician for CAC measurement with EBT. Subjects were
iven a risk-factor questionnaire to assess ethnicity and
ardiovascular risk factors. The presence and number of risk
actors for a subject was calculated on the basis of the
ational Cholesterol Education Program guidelines (1).
isk factors included: age (men 45 years, women 55
ears), current cigarette smoking, diabetes, history of pre-
ature coronary disease in first-degree relative (men 55
ears, women 65 years), hypertension, and hypercholes-
erolemia. Current cigarette smoking was defined as any
igarette smoking in the past month. Hypertension was
efined by current use of anti-hypertensive medication or
nown and untreated hypertension. Hypercholesterolemia
as defined as use of cholesterol lowering medication or, in
he absence of cholesterol lowering medication use, as
aving a total serum cholesterol 200 mg/dl. Total choles-
erol measurements were available in 11,275 subjects and
ere categorized as 200, 201 to 240, 241 to 260, and
260 mg/dl, respectively. Patients also noted whether they
ere taking statin therapy at the time of scanning.
BT methods. All study subjects underwent EBT with an
matron C-150XL Ultrafast computed tomography scanner
GE-Imatron, South San Francisco, California). The study
as approved by the Institutional Review Board of Harbor-
CLA Medical Center. Thirty to 40 contiguous tomo-
raphic slices were obtained at 3-mm intervals beginning
cm below the carina and progressing caudally to include
he entire coronary tree. Exposure time was 100 ms/
omographic slice, and total irradiation dose was 0.6
Sv/scan.
An attenuation threshold of 130 HU and a minimum of
contiguous pixels were used for identification of a calcific
esion. Each focus exceeding the minimum criteria was
cored with the algorithm developed by Agatston et al. (3),
alculated by multiplying the lesion area by a density factor
erived from the maximal HU within this area. The density
actor was assigned in the following manner: 1 for lesions
ith peak attenuation of 130 to 199 HU, 2 for lesions with
eak attenuation of 200 to 299 HU, 3 for lesions with peak
ttenuation of 300 to 399 HU, and 4 for lesions with peak
ttenuation 400 HU. The total CAC score was deter-
ined by summing individual lesion scores from each of 4
natomic sites (left main, left anterior descending, circum-
ex, and right coronary arteries) (3).
ollow-up data collection. Epidemiologic methods for
ollow-up included ascertainment of death by individuals
ho were blinded to historical and CAC score results (4,5).
he occurrence of all-cause death was verified with the
ational Death Index (6). Individuals who underwent
ardiovascular screening were followed for a mean of 6.8
ears (SEM 0.019) and median of 5.8 years (25th to 75th
ercentile  4.7 to 8.9 years). Follow-up was completed in c00% of patients. In this sample,
,218 patients had follow-up
10 years and 1,404 patients had
ollow-up 12 years.
ata validation in a prior
0,377 patient series. We com-
ared our survival analysis with a
imilar referral population from
atients enrolled in a prior regis-
ry (7,8) to examine near-term
3- to 5-year) versus long-term
7- to 10-year) survival. We
ooled both datasets for valida-
ion of our mortality model in
he current 25,253 patient series
nd the previously reported data
n 10,377 patients.
tatistical methods. We presented continuous measures as
ean  SD and frequency data as proportions. Categorical
ariables comparing CAC patient subsets with historical
ariables were compared with a chi-square likelihood ratio
est. For comparing CAC subsets by age and other contin-
ous measures, we employed analysis of variance techniques.
p value  0.05 was considered statistically significant.
Time to death from all causes was estimated with a Cox
roportional hazards model. Unadjusted survival and risk-
djusted survival rates controlling for age, gender, ethnicity,
nd other cardiac risk factors, detailed in Table 1, were
alculated. For all variables in a model, univariable and
isk-adjusted relative risk ratios (RRs) with 95% confidence
ntervals (CIs) were calculated.
Receiver-operating characteristic (ROC) curves were cal-
ulated, including a comparative analysis of age and other
ardiac risk factors (Table 1) versus the CAC score. From
he ROC curves, a concordance (or C-) index, a measure of
vent and non-event correct classification, was calculated
ncluding 95% CIs. In our first ROC curve analysis, we
valuated the area under the curve for age and other risk
actors as compared with the continuous CAC score. Two
OC curves are presented, including model 1: comparing
he number of cardiac risk factors with the continuous CAC
core, and model 2: comparing age with the continuous
AC score.
We then evaluated multivariable or risk-adjusted Cox
odels with the CAC score in several coding schemes: 1)
odel 1: total CAC score using categories of 0, 1 to 10, 11
o 100, 101 to 400, 401 to 699, 700 to 999, and1,000; and
) model 2: dividing the arterial segment analysis of the
AC score into 0 to 3 vessels with CAC score 100. In
articular, for each of these models, we calculated unad-
usted analyses as well as age-adjusted and other risk-factor-
djusted (Table 1) survival models. From the multivariable
odels, we evaluated the added value of the CAC score by
alculating a C-index and 95% CIs. As well, we calculated
he Delta chi-square, a measure of the risk predictive
Abbreviations
and Acronyms
CAC  coronary artery
calcium
CAD  coronary artery
disease
CHD  coronary heart
disease
CI  confidence interval
EBT  electron beam
tomography
ROC  receiver-operating
characteristic
RR  risk ratioontent of a given variable within a multivariable model.
Overall Clinical Characteristics of the Study Population by Coronary Calcium Patient Subsets
Table 1 Overall Clinical Characteristics of the Study Population by Coronary Calcium Patient Subsets
CAC Score
Overall
(n  25,253)
0
(n  11,046)
1–10
(n  3,567)
11–100
(n  5,033)
101–299
(n  2,616)
300–399
(n  561)
400–699
(n  955)
700–999
(n  514)
>1,000
(n  965) p Value
Average score 146 443 0 0 4 3 44 26 176 56 349 30 528 84 836 84 1,935 1,057 0.0001
Age, yrs (n  25,253) 56 11 52 10 53 10 57 10 61 10 63 10 64 10 66 9 68 10 0.0001
Male gender (n  13,659) 54% 52% 56% 54% 56% 59% 57% 58% 59% 0.0001
Ethnicity 0.0001
Caucasian (n  11,776) 77% 72% 77% 77% 83% 81% 83% 83% 83%
Hispanic (n  1,334) 9% 11% 9% 9% 6% 6% 7% 6% 4%
African American (n  637) 4% 5% 5% 4% 3% 4% 3% 3% 4%
Asian (n  1,065) 7% 9% 6% 6% 6% 6% 6% 5% 6%
Other (n  237) 2% 2% 2% 2% 1% 2% 1% 1% 2%
Asian Indian (n  248) 2% 2% 2% 2% 2% 1% 0.5% 1% 1%
American Indian (n  13) 0.1% 0.1% 0.1% 0.0% 0.1% 0.2% 0.2% 0.0% 0.0%
Native Hawaiian (n  4) 0.0% 0.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Hypertension (n  3,659) 15% 20% 29% 32% 39% 38% 43% 44% 45% 0.0001
Diabetes mellitus (n  961) 4% 4% 6% 8% 10% 11% 14% 16% 18% 0.0001
Hyperlipidemia (n  11,275) 18% 32% 40% 44% 45% 45% 45% 53% 45% 0.0001
Total cholesterol (mg/dl) 0.0001
200 6% 16% 13% 13% 13% 11% 11% 14% 16%
201–240 10% 24% 25% 23% 22% 22% 22% 16% 18%
241–260 3% 8% 9% 8% 7% 7% 7% 5% 4%
260 3% 7% 6% 6% 5% 6% 4% 4% 2%
On statin treatment 9% 11% 18% 22% 26% 23% 27% 34% 31% 0.0001
Family history of premature CAD (n  7,015) 58% 59% 58% 56% 59% 58% 58% 63% 60% 0.052
Current smoker (n  12,457) 9% 8% 9% 10% 10% 13% 12% 11% 10% 0.0001
Data are presented as whole percentages except when 1%, where data are presented to the tenth of a percent.
CAC  coronary artery calcium; CAD  coronary artery disease.
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May 8, 2007:1860–70 Long-Term Prognosis of CACTo understand to what extent longer-term outcomes
rom the current data series relates to near-term outcome,
e performed a comparative analysis of the variability in
ong-term survival as compared with previous reports on
ear term (i.e., 5-year) in the report by Shaw et al. (8). This
odeling was accomplished by pooling the datasets to
nclude the total CAC score as well as other cardiac risk
actors. A stratified Cox proportional hazards model was
sed to plot survival for the Shaw series and the current data
et. This was done to examine how longer-term outcome
ould further define risk in asymptomatic individuals. It
as our contention that the observation of 10 years might
rovide a closer approximation to longer-term outcome data
vailable from other asymptomatic cohort studies, such as
he Framingham study (7).
We also performed a post hoc sample size calculation for
he comparison of survival rates across CAC scores. The
alculations demonstrated that the available sample size of
5,253 patients was sufficiently large with a beta 0.80 and
lpha  0.01 to detect mortality differences between pa-
ients with CAC scores of 0, 1 to 10, 11 to 100, 101 to 400,
01 to 1,000, and 1,000, respectively (SamplePower,
ersion 2.0, SPSS Inc., Chicago, Illinois).
Finally, we evaluated the prevalence of CAC in this
linical registry as compared with other population esti-
ates, including data from MESA (Multi-Ethnic Study of
therosclerosis) and CARDIA (Coronary Artery Risk De-
elopment In Young Adults Study) as well as the Nashville
nd Torrance clinical registries with meta-analytic tech-
iques on the prevalence of detectable coronary calcium.
he frequency of calcium in each of the cohorts was
ompared with Comprehensive Meta-Analysis software (Bio-
tat, Englewood, New Jersey) with a random effects model.
esults
linical characteristics. Of the 25,253 patients, the aver-
ge age was 56  11 years with nearly one-half being male
nd having a family history of premature coronary artery
isease (CAD). The prevalence of cardiac risk factors was as
ollows: family history of premature CAD (58%), hypercho-
esterolemia (18%), hypertension (15%), smoking (9%), and
iabetes (4%). In the overall cohort, the average CAC score
as 146  443 (Table 1).
In subsets with more extensive CAC scores, patients
ere older and had more frequent cardiac risk factors.
early one-half of the patients with CAC scores 1,000
ere male (p  0.0001), hypertensive (p  0.0001),
yperlipidemic (p  0.0001), or had a family history of
remature CAD (p  0.052).
AC scores. More than one-half of patients had detect-
ble CAC (i.e., CAC 0). Detectable CAC was most
ommon in the left anterior descending and left circumflex
oronary arteries. By comparison, 11.9% and 35.0% of
atients had detectable CAC in the left main and right
oronary arteries (Table 2). vFor patients with detectable calcium, the average number
f lesions was 3.4 and 3.9 in the left anterior descending and
ight coronary arteries. Similarly, for patients with detect-
ble calcium, the average score/lesion ranged from 6 for a
eft main lesion to 30 for a left anterior descending coronary
rtery.
nivariable clinical risk factor and CAC predictors of
eath. Significant clinical predictors of death included age,
iabetes, smoking, male gender, hypertension, and family
istory of premature CAD (all p  0.0001). The relative
Rs for these cardiac risk factors ranged from 1.1 (95%
I 1.09 to 1.11)/decade of increasing age to 3.86 (95% CI
.03 to 4.92) for diabetes (both p  0.0001). The RR for
amily history of premature CAD was 0.63 (95% CI 0.51 to
.78) in large part because those referred for evaluation were
ounger (p  0.0001) (Table 3).
umulative long-term survival of CAC scores. Survival
aried significantly by the extent of CAC (p 0.0001) (Fig.
A). Unadjusted survival was 99.6%, 99.1%, 97.4%, 93.5%,
9.5%, 87.5%, 83.4%, and 73%, respectively, for CAC
cores of 0, 1 to 10, 11 to 100, 101 to 399, 400 to 699, 700
o 999, and 1,000 (p  0.0001). After adjustment for risk
actors, including age, in patients with CAC scores of 0, 1
o 10, 11 to 100, 101 to 399, 400 to 699, 700 to 999, and
1,000, 10-year survival was 99.4%, 99.3%, 98.1%, 96.6%,
4.7%, 93.9%, 92.4%, and 87.8%, respectively (p  0.0001)
Fig. 1A).
When compared with the 11,044 patients with no cal-
ium, scores of 1 to 10, 11 to 100, 101 to 399, 400 to 699,
00 to 999, and 1,000 showed RR of 2.56 (95% CI 1.54
o 4.27), 6.73 (95% CI 4.58 to 9.87), 12.83 (95% CI 8.71 to
8.91), 23.17 (95% CI 14.31 to 37.52), 27.58 (95% CI
8.19 to 41.80), 36.43 (95% CI 23.21 to 57.19), and 62.58
95% CI 43.04 to 91.00), respectively (p  0.0001). The
AC remained highly significant (p  0.0001) in a multi-
revalence of CAC Scores by Vascular Territory
Table 2 Prevalence of CAC Scores by Vascular Territory
Prevalence of CAC (%)
Total score 57.3%
Vascular territory score
Left anterior descending 54.5%
Left main 11.9%
Right coronary artery 35.0%
Circumflex 46.6%
Vascular territory—number of lesions
Left anterior descending 3.4 3.8 (0–99)
Left main 0.3 0.9 (0–30)
Right coronary artery 3.9 5.3 (0–69)
Circumflex 1.8 2.8 (0–34)
Average score/lesion
Left anterior descending 30 55 (0–1,566)
Left main 6 24 (0–580)
Right coronary artery 15 45 (0–1,860)
Circumflex 12 34 (0–988)
AC  coronary artery calcium.ariable model controlling for age, gender, ethnicity, diabe-
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Long-Term Prognosis of CAC May 8, 2007:1860–70es, hyperlipidemia, hypertension, as well as other cardiac
isk factors listed in Table 1. However, in the risk-adjusted
odel, the statistical difference between a CAC score of 0
s. 1 to 10 was no longer significant (p  0.29).
When grouped by the number of vascular territories with
AC scores of 100, a measure of atherosclerotic disease
xtent, survival varied significantly for patients with no
essel involvement as compared with 1 to 3 vessel CAC
isease. For patients with CAC 100, unadjusted survival
t 12 years was 98.8% as compared with survival rates of
0.4% (RR 3.81, 95% CI 2.63 to 5.53), 83.8% (RR 6.38,
5% CI 3.59 to 11.34), 78.0% (RR 8.41, 95% CI 2.70 to
.19), and 74.8% (RR 10.26, 95% CI 6.46 to 6.28),
espectively, for patients with 1, 2, and 3 vessel CAC and
eft main disease (p  0.0001). After adjustment for risk
actors including age, the survival at 12 years was 98.2% for
atients with a CAC score 100 as compared with survival
ates of 97.1%, 95.7%, and 94.6%, respectively, for patients
ith 1, 2, and 3 vessel CAC and left main disease (p 
Univariable Predictors of Death From All Causes
Table 3 Univariable Predictors of Death From
Relative
Clinical history
Age (/decade) 1.10
Diabetes 3.86
Smoking 3.10
Male gender 2.08
Hypertension 1.73
Family history of premature CAD 0.63
Hyperlipidemia 0.90
Coronary calcium results
CAC score categories of 1–10, 11–100,
101–299, 300–399, 400–699,
700–999, 1,000 vs. 0
1.68
Lesions
LM 1.31
Circumflex 1.15
RCA 1.07
LAD 1.06
Score
LM 2.19
LAD 1.68
Circumflex 1.61
RCA 1.56
Average lesion extent
LM 1.01
LAD 1.00
Circumflex 1.00
RCA 1.00
CAD extent (/vessel) 2.69
Description of CAC univariable models: 1) CAC score categories of 1–
model provides a univariable risk ratio for each category of increasing
risk ratio were not analyzed, because additional analyses within the res
lesions, this is an analysis of the total number of lesions within each v
of lesions when compared with no lesions in that vascular territory. 3)
vascular territory score/lesion identified within the LM, circumflex, RC
for a given average lesion extent. 4) The CAD extent analysis includes
CAC coronary artery calcium; CAD coronary artery disease; CI
territory; RCA  right coronary artery territory..0001) (Fig. 1B). sWe further evaluated the long-term survival in patients with
ingle vessel CAC scores ranging from 11 to 100 (Fig. 1C)
welve-year unadjusted survival ranged from 99.4% for no
essel involvement to 84.7% for patients with 3 vessels with
cores of 11 to 100 (p  0.0001). Risk-adjusted survival for
atients with CAC scores from 11 to 100 is plotted in Figure
C (p  0.0001). The ensuing risk-adjusted RR was elevated
.66-fold (p  0.031) and 1.84-fold (p  0.003) for patients
ith 3 vessel and 3 vessel plus left main CAC scores from 11
o 100 as compared with CAC score 11 in any of the major
picardial coronary arteries.
omparative analysis of 5- and 12-year survival from 2
atabases. Previous reports have limited follow-up from 3
o 5 years of observation (8). To compare near- and
ong-term outcome by CAC scores, we examined unad-
usted and risk-adjusted survival in cohorts from Nashville,
ennessee (n  10,377) and Los Angeles, California (n 
5,253) (Fig. 2). There were no differences in prevalence of
AC in each cohort (p  0.88) (Table 4). Cumulative
everse Order by Chi-Square Value
auses—in Reverse Order by Chi-Square Value
95% CI Chi-Square p Value
1.09–1.11 585 0.0001
3.03–4.92 137 0.0001
2.43–3.95 92 0.0001
1.72–2.52 59 0.0001
1.40–2.14 26 0.0001
0.51–0.78 19 0.0001
0.70–1.16 1 0.42
1.63–1.74 1,181 0.0001
1.27–1.35 560 0.0001
1.13–1.18 209 0.0001
1.06–1.08 186 0.0001
1.05–1.07 156 0.0001
1.99–2.41 326 0.0001
1.57–1.81 238 0.0001
1.52–1.71 279 0.0001
1.46–1.67 174 0.0001
1.008–1.011 401 0.0001
1.003–1.004 256 0.0001
1.004–1.006 256 0.0001
1.002–1.004 225 0.0001
2.35–3.08 270 0.0001
–100, 101–299, 300–399, 400–699, 700–999, 1,000 vs. 0: This
tent (n  7 categories) as compared with a CAC score of 0. Individual
vides risk-adjusted risk ratios. 2) For the LM, circumflex, RCA, and LAD
territory; as such, the risk ratio reveals the increase for every number
average lesion extent univariable analysis, this examines the average
LAD areas. Thus, the risk ratio reveals the x-fold increase in mortality
mber of vascular territories with scores 100.
nce interval; LAD left anterior descending territory; LM left main—in R
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May 8, 2007:1860–70 Long-Term Prognosis of CACith CAC scores of 0 to 10 to 1,000 (p  0.0001). In a
tratified Cox model with follow-up up to 5 years after
maging, survival was similar between the 2 cohorts for
atients with a CAC score 0 to 10, 11 to 100, 101 to 400,
01 to 1,000, and 1,000 (all p  0.90). By 12 years of
ollow-up, cumulative survival rates were 99.4%, 97.8%,
4.5%, 93.0%, and 76.9% for patients with CAC scores of
to 10, 11 to 100, 101 to 400, 401 to 1,000, and 1,000,
espectively (p  0.0001). Risk of mortality for each score
ategory increased with increasing score. In comparing
urvival rates between the Nashville, Tennessee and Tor-
Figure 1 Risk-Adjusted Cumulative Survival by CAC Score
Risk adjustment included the following variables: age, hypercholesterolemia, diabe
(A) Subsets ranging from 0 to 1,000. The increasing calcium scores were assoc
significant increased risk of all-cause mortality (chi-square  1,363, p  0.0001 f
0.0001, and chi-square  274 for variable (p  0.0001 overall and for each cate
are plotted within a range of 0.90 to 1.00. (B) Cumulative survival by the coronary
age and risk factors. There was worsening survival with increasing number of calci
and chi-square  27 for variable (p  0.0001 overall and p value for each catego
posed on the left main subset and, for that reason, the 2 were combined to form
scores in the range of 11 to 100. Even in patients with small amounts of CAC, inc
(chi-square  182, p  0.0001 for the variable and for each category subset). Mo
overall and p value for each category subset is stated in figure).ance, California databases, mortality increased from 0.7% cp  0.0073) to 4.9% (p  0.0001) for more extended
ollow-up from the Torrance registry; even in risk-adjusted
odels that controlled for age, gender, hypertension, hy-
erlipidemia, and diabetes (Fig. 2).
isk-adjusted models. In several risk-adjusted models
Table 5), CAC scores remained independently predictive
f all-cause mortality even after adjusting for age, gender,
thnicity, hypertension, hyperlipidemia, diabetes, smoking,
nd family history of premature CAD.
dded value of CAC versus traditional risk factors.
ith the CAC score, the C-index defined from a ROC
moking, hypertension, and a family history of premature coronary heart disease.
with worsening survival. Each increment of calcium score was associated with
able overall and for each category subset). Model chi square  2,017, p 
bset). Scale on this curve is from 0.80 to 1.00, whereas the remaining curves
m extent in the number of vascular territories with scores 100, adjusted for
ssels (chi-square  251, p  0.0001). Model chi-square  1,290, p  0.0001,
set is stated in figure). The survival curve for 3 vessel (n  28) was superim-
gory. (C) Cumulative survival in patients with coronary artery calcium (CAC)
g number of vessels involved was associated with worsening long-term survival
i-square  1,148, p  0.0001, and chi-square  13 for variable (p  0.013tes, s
iated
or vari
gory su
calciu
fied ve
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Long-Term Prognosis of CAC May 8, 2007:1860–70igher than that observed for a model of the number of
ardiac risk factors (C-index  0.611; 95% CI 0.585 to
.637) (Fig. 3A). Of the available risk factor data (see Fig.
B), age provided the best discrimination in mortality with
AC providing additional statistical information (p 
.0001).
Table 5 includes C-indexes from multivariable models. In
hese risk-adjusted models, the CAC scores remained inde-
endently predictive of mortality even when applying categor-
cal or vascular territory scores (Table 5). Additionally, the %
nformation content ranged from 4% to 14% for the CAC
core when considering all other traditional risk factors.
iscussion
his cohort represents the largest and longest follow-up
fter scanning for CAC. This long-term follow-up re-
eals that coronary calcium scores 10 are predictive of
revalence of CAC by Dataset
Table 4 Prevalence of CAC by Dataset
Nashville Harbor-UCLA
0–10 57% 58%
11–100 20% 20%
101–400 14% 13%
401–1,000 6% 6%
1,000 3% 4%
Figure 2 Near- and Long-Term Survival From 2 EBT Centers: Na
Comparison of 5-year mortality rates in 2 different cohorts. The results are quite c
different study groups (chi-square  1,503, p  0.0001, interaction p  0.0001)v
hi-square linear p trend, p  0.88.
CAC  coronary artery calcium.n increased risk, potentially reducing the threshold for
nstituting aggressive medical therapy (e.g., statins, aspi-
in). The end point, all-cause mortality, with over 500
vents, provides this investigation with sufficient statis-
ical power (beta 0.80) to evaluate the prognostic
ignificance of CAC. The results are concordant with
ther similar studies, demonstrating that increasing
laque burden is associated with increasing risk. Earlier
eports on this modality were based on highly selected
ohorts with the numbers of end points often being quite
ow. This study, similar to the study by Shaw et al. (8),
sed all-cause mortality as a more definitive end point.
ll-cause mortality is not subject to misclassification of
he cause of death on physician’s reports (9). Further-
ore, in the U.S., atherosclerosis accounts for a sizeable
roportion of deaths, and more so in a population at-risk
or the disease (10). Thus, our analysis that was con-
ucted, with established epidemiologic methods in a
ufficiently large population, showed that the extent of
AC is highly correlated with mortality risk. The present
tudy, a large cohort with long follow-up, provides
upportive evidence that there is a linear relationship
etween the extent of CAC and all-cause mortality.
The calcium score also added incremental value to vari-
bles contained within the Framingham risk model. When
AC scores were added to risk factors in patients in the
tudy by Shaw et al. (8), the estimation of risk increased
le, Tennessee, and Los Angeles, California
ent across
 coronary artery calcium; EBT  electron beam tomography.shvil
onsist
. CACis-à-vis a significant improvement in the C-index (p 
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May 8, 2007:1860–70 Long-Term Prognosis of CAC.001). In our analyses with an array of univariable and
ultivariable methodologies, C-indexes consistently im-
roved after the addition of CAC measures to risk factor
odels (p  0.0001). The C-index and odds ratio similarly
ncreased in other large studies of CAC. A study by Raggi
t al. (11) demonstrated odds ratios of 21.5 for future hard
ardiovascular events for patients in the highest quartile of
alcium scores. That correlates well with this study, in
hich a score of 300 to 399 was associated with an RR of
3, and score of 400 to 699 with an RR of 27, as compared
ith patients without CAC. In the St. Francis Heart Study
12), in which over 4,900 patients were followed for 4.3
ears, a score 400 was associated with a 30-fold increased
isk for CAD death or myocardial infarction. From this
eport by Arad et al., the CAC score predicted CAD events
isk-Adjusted Models for All-Cause Death
Table 5 Risk-Adjusted Models for All-Cause Death
Relative Risk 95% CI
Model† 1: CAC score
Overall 1.31 1.23–1.39
1–10 1.48 0.71–3.07
11–100 3.61 2.11–6.18
101–399* 3.84 2.20–6.68
400–699 5.78 3.00–11.1
700–999 6.47 3.37–12.4
1,000 9.36 5.36–16.3
Model† 2: CAD extent (/vessel)
Overall 1.58 1.28–1.96
1-vessel 1.39 0.95–2.03
2-vessel 1.85 1.03–3.30
3-vessel or left main 2.44 1.58–3.78
For this risk-adjusted model, survival was similar for categories of 101–299 and 300–399 and w
iabetes, family history of premature coronary disease, smoking, and ethnicity. C-index for risk fa
isk factor data (p  0.0001 for model 1 and p  0.008 for model 2).
Abbreviations as in Table 3.
Figure 3 Receiver-Operating Characteristic Curves Noting the I
Agatston Scores Over and Above the Total Number of
These curves note the available data revealing the highest area under the curve fo
significant improvement in the area under the curve (p  0.0001 for the total num
other individual risk factors were 0.586 for gender, 0.440 for family history, 0.5
0.562 for hypertension.ore accurately than the Framingham risk index. The area
nder the ROC curve was 0.79 0.03 for the calcium score
ersus 0.68 0.03 for the Framingham index (p 0.0006).
n the recently reported Prospective Army Coronary Cal-
ium Project, in which younger patients were evaluated with
BT and followed prospectively, CAC was associated with
12-fold increased risk for hard CHD events (p  0.004)
ven after controlling for the Framingham risk score (13).
In the current study, patients with CAC scores 1,000
ad a very high risk of all-cause mortality. This parallels the
ncidence of hard cardiac events demonstrated by Wayhs
t al. (14), in which patients with CAC scores 1,000 had
25% 1-year event rate. A recent study also demonstrated
isk stratification in 510 uncomplicated type-2 diabetic
atients prospectively enrolled and undergoing CAC (15).
% of Chi-Square p Value C-Index*
14% (274/2,017) 0.0001 0.757 (0.728–0.787)
0.29
0.0001
0.0001
0.0001
0.0001
0.0001
4% (25/677) 0.0001 0.552 (0.511–0.592)
0.086
0.038
0.0001
lapsed for this analysis. †Risk-adjusted controlling for age, gender, hypertension, hyperlipidemia,
a  0.354 (0.312–0.395). The C-indexes for CAC were significantly greater than classification by
ental Value of the Total
cal Risk Factors as Well as Age
al risk factors. In both cases, the addition of the Agatston score resulted in a
risk factors [A] and for age [B]). Receiver-operating characteristic analysis for
smoking, 0.577 for diabetes, 0.518 for ethnicity, 0.484 for hyperlipidemia, and6
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Long-Term Prognosis of CAC May 8, 2007:1860–70he ROC analysis demonstrated that CAC predicted
ardiovascular events with the best area under the curve
0.92), significantly better than the United Kingdom Pro-
pective Diabetes Study Risk Score (0.74) and Framingham
core (0.60) (p  0.0001). The RR to predict a cardiovas-
ular event for a CAC score of 101 to 400 was 10.1 and
ncreased to 58.1 for scores 1,000 (p  0.0001). Our
ohort similarly demonstrated unadjusted relative risks from
2.8 to 62.6 for similar CAC groups.
Patients without evidence of CAC in this study experi-
nced a very low event rate, with 12-year survival of 99.4%.
his low event rate in patients without CAC has been
bserved in other studies. Arad et al. (12) demonstrated an
nnual event rate of 0.1%, Taylor et al. (13) demonstrated
n event rate of 0.06%, and Raggi et al. (11) demonstrated
n annual event rate of 0.11% for persons with no detectable
AC by EBT. Indeed, even a cohort of approximately 900
iabetic patients followed for 5-year survival was 98.8% in
he absence of CAC (16). In that study, diabetic and
on-diabetic patients with no CAC demonstrated a similar
urvival (98.8% and 99.4%, respectively, p  0.5). In a
rospective study of type-2 diabetic patients, no cardiac
vents or perfusion abnormalities occurred in subjects with
CAC score 10 through 2 years of follow-up (15). The
nly study reporting a higher event rate for 0 scores used
typical image acquisition and quantification of CAC,
elying on thick slices (6 mm) and large areas of calcification
17), which has been shown to result in data loss (18).
The low risk associated with a 0 score provides further
vidence that these patients, despite some high risk at-
ributes, might be at sufficiently low risk to recommend
gainst cholesterol-lowering drug therapy (given the cost)
nd aspirin therapy (given the risk of hemorrhagic stroke
ssociated with aspirin use) (2). Conversely, a score higher
han 100 might lead to the recommendation of continued
spirin use and more aggressive lipid control aiming for a
oal low-density lipoprotein-C level of 100 mg/dl, as
uggested currently by the National Cholesterol Education
rogram-Adult Treatment Panel III (NCEP-ATP III): “In
ersons with multiple risk factors, high coronary calcium
cores (e.g., 75th percentile for age and gender) denote
dvanced coronary atherosclerosis and provide a rationale
or intensified low-density lipoprotein–lowering therapy”
19). Current recommendations are to use cardiac com-
uted tomography for measuring CAC in individuals
etermined to be at intermediate clinical risk according
o the NCEP-ATP III criteria and in whom decisions
oncerning prevention strategies might be altered on the
asis of the test results (20).
tudy limitations. Although the current article includes a
igorous analysis of the prognostic value of CAC, the
ajority of patients referred for calcium scanning had
ardiac risk factors and, as such, are not representative of the
eneral population. We had incomplete information related
o cardiovascular risk factors, because these measures were
aken by survey rather than being measured. The prevalence wf hypercholesterolemia, hypertension, and diabetes in our
opulation was similar to that observed in other large,
opulation-based studies of CHD (21) and in studies on
AC and CHD (7,22–24). Recent large epidemiologic
tudies (NIH-NHLBI MESA and CARDIA) (25) demon-
trate similar prevalence rates for CAC compared with our
ohort (Fig. 4). Thus, results from the current cohort seem
imilar to population-based estimates of atherosclerosis.
Previous studies have demonstrated a sensitivity of 98%
nd a specificity of 99% for self-reported hypertension as
ompared with measured values (26). We expect that our
ell-educated population would similarly fall into these
evels of precision. It is expected that the inclusion of
easured risk factors, such as systolic blood pressure, blood
lucose level, and cholesterol values, would provide a better
stimation of risk than historical data alone. However, the
se of categorical risk factors instead of continuous variables
as been shown to constitute a valid approach to risk
ssessment (27). Hence, we believe that a risk assessment
pproach on the basis of historical risk factors rather than on
ontinuous variables does not significantly weaken the
ssumptions made in this study.
We observed a decrement in predictive capabilities for
isk factor models (i.e., the C-index was lower for categor-
cal risk factors as compared with the CAC score), including
amily history of premature disease, smoking, and diabetes.
he reduced C-indexes for traditional cardiac risk factors,
Figure 4 Comparative Analysis of Population Sample
Prevalence Rates for Coronary Calcification
This study (Los Angeles) demonstrates similar prevalence to the prior all-cause
mortality study from Nashville, Tennessee, and only slightly greater prevalence
than the CARDIA (Coronary Artery Risk Development In Young Adults) study and
MESA (NIH-NHLBI Multi-Ethnic Study of Atherosclerosis).e believe, are the result of concurrent treatment for
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May 8, 2007:1860–70 Long-Term Prognosis of CACypertension, diabetes, and hypertension as well as a
ounger age for screening patients with a family history of
remature coronary disease. However, use of categorical risk
actors results in an underestimation in their predictive
bilities. Despite this limitation, the availability of categor-
cal risk factor data is consistent with current clinical
ractice where physicians are generally limited by the
vailability of only partial, self-reported, categorical data.
herefore, there is a possibility that the value of CAC
esting is being overinflated when measured with observed
isk factors, as compared with measured risk factors.
Information on subsequent therapy after calcium scan-
ing is unknown. We have previously demonstrated that
atients with higher calcium burdens are more likely to be
laced on statin therapy and more likely to maintain statin
herapy (improved adherence) over the subsequent 3 to 5
ears (28). Thus, higher calcium scores are confounded by
mproved anti-atherosclerotic therapies that would pos-
ibly lower cardiovascular mortality. However, this con-
ounder would weaken the predictive value of coronary
alcification.
Additionally, the National Death Index data do not
nclude the cause of death and, as such, our models include
ortality possibly unrelated to atherosclerotic disease.
owever, the bias resulting from death misclassification
oes not occur in all-cause mortality models, and in this age
roup, the prevalence of CHD deaths has been reported to
e approximately one-third of death from all-causes (29). If
wo-thirds of deaths in the American population are unre-
ated to coronary disease risk factors, it is possible that the
ddition of standard CAD risk factors to age would reduce
he accuracy of the predictive model for all-cause mortality.
owever, the cardiovascular death rate, in a patient popu-
ation referred with cardiovascular risk factors, should be
uch higher than general population estimates. Patients
ith active cancer, acquired immune deficiency syndrome,
ongestive heart failure, or advanced lung disease were
enerally not referred for calcium scoring to assess cardio-
ascular risk.
onclusions
e collected mortality data on 25,253 consecutive, asymp-
omatic individuals referred by primary care physicians for
AC scanning. This large observational data series strongly
ndicates that CAC is an independent estimator of all-cause
ortality. Our results reveal a marked difference in survival
t 6.8 years as the CAC scores increase from 0 to 1,000.
his supports the notion that increasing coronary athero-
clerosis is a strong and independent predictor of future
ardiac events. Furthermore, our study shows that CAC
rovides independent and incremental prognostic informa-
ion in addition to traditional risk factors in the prediction
f all-cause mortality.eprint requests and correspondence: Dr. Matthew J. Budoff,
arbor-UCLA Research and Education Institute, 1124 West
arson Street, RB2, Torrance, California 90502. E-mail:
budoff@labiomed.org.
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